# South Korea High Flow Nasal Cannula Market > South Korea High Flow Nasal Cannula Market Research Report: Size, Share, Trend Analysis By Component (Nasal Cannulas, Air Humidifiers, Single Heated Tubes, Air/Oxygen Blenders, Others), By Applications (Carbon Monoxide Toxicity, Acute Respiratory Failure, Bronchiectasis, Chronic Obstructive Pulmonary Disease (COPD), Sleep Apnea, Others) andBy End-User (Long-Term Care Centers, Hospitals, Ambulatory Care Services, Others) - Growth Outlook & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 12.99% - **2024:** $ 178 Million - **2025:** $ 201.12 Million - **2035:** $ 682 Million - **Key Players:** Fisher & Paykel Healthcare (NZ), Medtronic (IE), Philips (NL), ResMed (AU), Smiths Medical (GB), Teleflex (US), Vyaire Medical (US), Becton Dickinson (US) **Report ID:** MRFR/MED/50473-HCR · **Pages:** 200 · **Author:** Satyendra Maurya & Garvit Vyas · **Last Updated:** August 24, 2026 **URL:** https://www.marketresearchfuture.com/reports/south-korea-high-flow-nasal-cannula-market-52231 --- ## Market Summary ## **South Korea High Flow Nasal Cannula Market Overview** As per MRFR analysis, the South Korea High Flow Nasal Cannula Market Size was estimated at 197.5 (USD Million) in 2023. The South Korea High Flow Nasal Cannula Market Industry is expected to grow from 222.5 (USD Million) in 2024 to 779 (USD Million) by 2035.The South Korea High Flow Nasal Cannula Market CAGR (growth rate) is expected to be around 12.066% during the forecast period (2025 - 2035). ### **Key South Korea High Flow Nasal Cannula Market Trends Highlighted** The South Korea High Flow Nasal Cannula is changing quickly because people have more health problems as well as technological advancements within the field of healthcare. Another notable reason is the growing population in South Korea since the elderly need better methods to oxygen due to their number of health issues. Technology within the healthcare field is always improvising for better results upon patients hence there is a recurring shift towards high flow nasal cannula systems, which is far more comfortable than the traditional ones. The exacerbation of chronic breathing diseases such as COPD is an additional reason for the increased need of these devices. The South Korean market is also expanding as the healthcare providers continue to improve on patient management and recovery processes. The use of high flow nasal cannula devices in hospitals and home care is on the rise. Increased understanding by healthcare professionals of the usefulness of these devices in managing and treating respiratory diseases provides a great potential market for manufacturers and distributors. There is also government backing for innovation in healthcare, especially in funding programs aimed at developing better technologies for caring for the respiratory system. Recently, important trends in the market include focusing on the overall ease of use and portability of the device for patients, in post-operative and outpatient settings. As telemedicine becomes more widely used, high flow nasal cannula systems are being incorporated into more remote monitoring solutions, Continuity of patient care and accessibility are guaranteed. Increased attention towards research and development for respiratory therapy is likely to result in new breakthroughs, ensuring continued growth and responsiveness to patients in the South Korean High Flow Nasal Cannula market. ## **South Korea High Flow Nasal Cannula Market Drivers** ### **Increasing Prevalence of Respiratory Diseases** The South Korea High Flow Nasal Cannula Market industry is witnessing significant growth due to the rising prevalence of respiratory diseases such as [Chronic Obstructive Pulmonary Disease (COPD)](../../../reports/chronic-obstructive-pulmonary-disease-copd-market-1612) and asthma. According to the Korea Centers for Disease Control and Prevention, approximately 8% of adults in South Korea suffer from COPD, and this number is projected to increase as the population ages. With the ageing population in South Korea, expected to reach over 40% aged 65 and above by 2025, the demand for effective respiratory support, such as high flow nasal cannulas, will significantly rise. Furthermore, organizations like the Korean Respiratory Society are continually emphasizing the importance of advanced treatments for respiratory issues, stimulating market growth in the region. This situation indicates that the South Korea High Flow Nasal Cannula Market is well-positioned to cater to an increasingly health-conscious demographic seeking advanced therapeutic options. ### **Technological Advancements in Medical Devices** Recent technological advancements in medical equipment are propelling the growth of the South Korea High Flow Nasal Cannula Market industry. Innovations in design, such as improved patient comfort and more efficient oxygen delivery systems, are setting new industry standards. For example, the introduction of heated humidified High Flow Nasal Cannula systems has been shown to enhance patient outcomes, particularly in intensive care units and emergency settings. The Ministry of Health and Welfare in South Korea has initiated programs to facilitate Research and Development (R&D) in healthcare technologies, promoting investments from both local and international companies. This focus on technological innovation not only enhances the effectiveness of treatments but also draws more healthcare providers to adopt high flow nasal cannulas, thereby driving market growth. ### **Growing Investment in Healthcare Infrastructure** The South Korean government is substantially increasing its investments in healthcare infrastructure, which positively impacts the South Korea High Flow Nasal Cannula Market industry. The government unveiled a national plan to invest over 100 trillion Korean Won in healthcare facilities by 2025, aiming to enhance hospital capabilities, particularly in critical care. As more healthcare facilities are upgraded, there will be a corresponding increase in the availability and use of advanced medical equipment, including high flow nasal cannulas. According to the Health Insurance Review and Assessment Service, the number of intensive care units in South Korea has already seen a 15% increase over the past five years, demonstrating an upward trend in healthcare capabilities. This growing healthcare infrastructure will facilitate more effective management of respiratory diseases, showcasing a robust growth opportunity for the South Korea High Flow Nasal Cannula Market. ### **Rising Awareness and Adoption of Non-Invasive Ventilation** There is an increasing awareness among healthcare providers and patients regarding non-invasive ventilation methods, which is driving the South Korea High Flow Nasal Cannula Market industry. The Korean Society of Critical Care Medicine has reported that non-invasive ventilation techniques are gaining recognition for their benefits in managing respiratory failure. Among these methods, high flow nasal cannulas are highlighted for their ease of use and comfort among patients, making compliance better compared to traditional forms of ventilation. Educational campaigns from professional medical organizations are amplifying the adoption rates, with a reported 20% increase in the use of high flow nasal cannulas in hospitals over the last two years. Such efforts are crucial as they influence hospitals to stock more of these devices, thereby contributing to the overall market growth. ## **South Korea High Flow Nasal Cannula Market Segment Insights** ### **High Flow Nasal Cannula Market Component Insights** The Component segment of the South Korea High Flow Nasal Cannula Market plays a significant role in the overall dynamics of respiratory care, enhancing oxygen delivery and patient comfort. This segment includes various essential parts such as Nasal Cannulas, Air Humidifiers, Single Heated Tubes, Air/Oxygen Blenders, and Others. Nasal Cannulas are particularly crucial as they provide efficient methods for delivering high-flow oxygen therapy, contributing to improved patient outcomes in acute and chronic respiratory conditions. Air Humidifiers serve a vital purpose by preventing mucosal drying and ensuring the comfort of patients undergoing long-term oxygen therapy. Single Heated Tubes enhance the effectiveness of high flow therapy by maintaining the proper temperature and humidity levels of the air being delivered, addressing the challenges of condensation and ensuring a consistent flow. Air/Oxygen Blenders are critical for achieving precise control over various oxygen concentrations, which helps in tailoring treatment based on individual patient needs. Together, these components contribute significantly to the growing demand for high flow nasal therapy solutions. As the South Korea High Flow Nasal Cannula Market evolves, advancements in technology and a rising focus on patient-centric care are anticipated to enhance the functionalities of these components, fostering innovation and expanding treatment applications. According to the latest South Korea High Flow Nasal Cannula Market data, the increasing prevalence of respiratory diseases, coupled with an aging population, drives the need for effective respiratory care solutions. Additionally, owing to the surge in awareness regarding the benefits of high flow nasal therapies in clinical settings, hospitals are adopting these technologies at a favorable rate. However, challenges such as the initial costs of advanced systems and the need for trained personnel may impact the growth trajectory in some aspects. Despite these challenges, opportunities abound in this sector, particularly for innovative designs and smart technologies that cater to the evolving demands of healthcare providers and patients alike. Furthermore, the South Korea High Flow Nasal Cannula Market statistics reveal that there is considerable investment in Research and Development to introduce next-generation high flow nasal cannula components that enhance comfort and minimize the risk of complications. This trend reflects a broader movement in the healthcare industry aimed at improving patient experience while ensuring effective respiratory management. Overall, the Component segment continues to evolve, highlighting the importance of continuous innovation and adaptation in meeting the needs of a diverse patient population within the healthcare system of South Korea. ### **High Flow Nasal Cannula Market Application Insights** The South Korea High Flow Nasal Cannula Market focuses on various applications that address critical respiratory conditions. Each application plays an essential role in enhancing patient outcomes and managing a range of complications. Carbon Monoxide Toxicity necessitates timely intervention, and high flow nasal cannulas provide excellent oxygen delivery which is crucial in emergency situations. Similarly, Acute Respiratory Failure represents a significant burden on the healthcare system, where the demand for efficient oxygen therapy continues to rise. The Chronic Obstructive Pulmonary Disease (COPD) segment is particularly notable as it encompasses a vast population in South Korea, reflecting the growing prevalence of respiratory diseases in an aging demographic. Furthermore, Sleep Apnea is increasingly recognized, where high flow nasal cannula therapy can improve sleep quality and reduce healthcare costs related to chronic conditions. Bronchiectasis and other respiratory ailments also require innovative oxygen therapy solutions, contributing to the diverse content of the application landscape. Overall, advancements in technology and increased awareness among healthcare providers are driving the relevance of these applications within the South Korea High Flow Nasal Cannula Market, fostering growth opportunities across the board. ### **High Flow Nasal Cannula Market End-User Insights** The End-User segment of the South Korea High Flow Nasal Cannula Market plays a crucial role in addressing respiratory needs across various healthcare settings. Hospitals are key players, often utilizing high flow nasal cannulas for patients requiring acute respiratory support, thereby enhancing patient recovery rates. Long-Term Care Centers have increasingly recognized the importance of these devices in managing chronic respiratory diseases, providing an effective means of oxygen delivery to patients with long-term needs. Ambulatory Care Services also contribute significantly, offering outpatient solutions that utilize high flow nasal cannulas for patients who may not require intensive care but still need supplemental oxygen. The diverse applications within these settings highlight the versatility and importance of the high flow nasal cannula technology in improving patient outcomes. With the growing prevalence of respiratory conditions in South Korea, each of these End-User categories is primed for expansion, ultimately driving the evolution of healthcare delivery in the region and ensuring better management of respiratory therapies. ## **South Korea High Flow Nasal Cannula Market Key Players and Competitive Insights** The South Korea High Flow Nasal Cannula Market is witnessing a dynamic competitive landscape driven by advancements in respiratory devices and increased adoption of high flow oxygen delivery systems. The rising prevalence of respiratory conditions and the growing awareness of non-invasive ventilation therapies are contributing to the market's growth. Key players are continuously innovating their product offerings to enhance patient outcomes and improve comfort. The competition is intense, with companies focusing on technological enhancements, strategic partnerships, and customer-centric solutions to capture a more significant share of this burgeoning market. Philips has established a strong foothold in the South Korean High Flow Nasal Cannula Market through its commitment to innovation and quality. The company leverages its advanced technology to develop high-performance devices that cater to both hospital settings and outpatient treatments. Philips has built a reputation for reliability and efficacy in its respiratory care products, making it a preferred choice among healthcare professionals. Their emphasis on research and development allows them to introduce state-of-the-art solutions that meet the specific needs of the South Korean healthcare market. Moreover, their effective distribution and support network ensure that their products are readily available, reinforcing their competitive advantage in this space. ResMed is another key player in the South Korean High Flow Nasal Cannula Market, known for its focus on cloud-connected devices and advanced respiratory care solutions. The company offers a range of products designed specifically for high flow oxygen therapy, paralleling the latest advancements in telehealth and home healthcare. ResMed's strength lies in its robust research capabilities and continuous investment in innovative technologies, which allows it to provide effective solutions for patients with chronic respiratory diseases. The company also actively pursues strategic partnerships and collaborations to enhance its product offerings and expand market reach in South Korea. Through mergers and acquisitions, ResMed has strengthened its position by integrating new capabilities and technologies that cater to the local market's needs. Overall, ResMed's dedication to quality, innovation, and strategic growth positions it as a formidable competitor in this emerging market segment. ### **Key Companies in the South Korea High Flow Nasal Cannula Market Include** ## **South Korea High Flow Nasal Cannula Market Industry Developments** Recent developments in the South Korea High Flow Nasal Cannula Market have been marked by increased demand due to the ongoing focus on respiratory care, particularly stemming from the COVID-19 pandemic. As healthcare facilities expand their capabilities, companies like Philips, ResMed, and Fisher and Paykel Healthcare have been actively enhancing product offerings to meet clinical needs. In terms of mergers and acquisitions, notable movements include ResMed acquiring an undisclosed respiratory device company in July 2023, aimed at broadening its product portfolio in South Korea. Furthermore, during 2022, Drive DeVilbiss Healthcare launched innovative cannula designs that cater to patients' comfort, thus strengthening their market presence. Market valuations for these firms continue to grow, with Air Liquide reporting a substantial increase in their revenue attributed to higher demand for medical gases and respiratory devices. The South Korean government is investing in advanced medical technologies, contributing to the overall growth of the market. Companies are also focusing on Research and Development to innovate and create high-quality products that cater to the evolving healthcare landscape in South Korea. ## **South Korea High Flow Nasal Cannula Market Segmentation Insights** ### **High Flow Nasal Cannula Market Component Outlook** ### **High Flow Nasal Cannula Market Application Outlook** ### **High Flow Nasal Cannula Market End-User Outlook** ## Market Drivers ### Aging Population and Healthcare Needs South Korea's demographic shift towards an aging population is significantly impacting the high flow-nasal-cannula market. With over 15% of the population aged 65 and older, there is a growing demand for healthcare services tailored to older adults, many of whom experience respiratory issues. This demographic trend suggests a potential increase in the utilization of high flow-nasal-cannula systems, as they offer a more comfortable and effective means of oxygen delivery. Furthermore, the government is investing in healthcare infrastructure to support this aging population, which may lead to increased availability and accessibility of high flow-nasal-cannula devices in hospitals and clinics. As a result, the market is expected to expand in response to these evolving healthcare needs. ### Increased Focus on Patient-Centric Care The shift towards patient-centric care in South Korea is driving the high flow-nasal-cannula market. Healthcare providers are increasingly prioritizing patient comfort and satisfaction, leading to a preference for non-invasive treatment options. High flow-nasal-cannula systems are designed to enhance the patient experience by providing higher levels of oxygen with less discomfort compared to traditional methods. This focus on patient-centric solutions aligns with the broader trends in healthcare, where outcomes and quality of life are paramount. As hospitals and clinics adopt these practices, the demand for high flow-nasal-cannula devices is likely to rise, reflecting a significant market opportunity for manufacturers and suppliers. ### Rising Prevalence of Respiratory Disorders The increasing incidence of respiratory disorders in South Korea is a crucial driver for the high flow-nasal-cannula market. Conditions such as chronic obstructive pulmonary disease (COPD) and asthma are becoming more prevalent, leading to a heightened demand for effective oxygen delivery systems. According to recent health statistics, approximately 7.5% of the population suffers from some form of respiratory ailment, which necessitates advanced therapeutic solutions. The high flow-nasal-cannula market is positioned to address these needs, providing a non-invasive method for oxygen therapy that enhances patient comfort and compliance. As healthcare providers seek to improve patient outcomes, the adoption of high flow-nasal-cannula systems is likely to increase, thereby driving market growth in the region. ### Technological Innovations in Medical Devices Technological advancements in medical devices are playing a pivotal role in shaping the high flow-nasal-cannula market. Innovations such as improved flow rate control, integrated humidification systems, and enhanced comfort features are making these devices more effective and user-friendly. The introduction of smart technologies, including real-time monitoring and data analytics, is also enhancing the functionality of high flow-nasal-cannula systems. These advancements not only improve patient outcomes but also attract healthcare providers looking for cutting-edge solutions. As the market continues to evolve, the integration of technology into high flow-nasal-cannula devices is expected to drive growth and adoption in South Korea. ### Government Initiatives and Funding for Healthcare Government initiatives aimed at improving healthcare access and quality in South Korea are significantly influencing the high flow-nasal-cannula market. Increased funding for respiratory care programs and the promotion of innovative medical technologies are key factors driving market growth. The government has implemented policies to enhance the availability of advanced medical devices, including high flow-nasal-cannula systems, in both urban and rural healthcare settings. This support not only facilitates the adoption of these devices but also encourages manufacturers to invest in research and development. As a result, the high flow-nasal-cannula market is likely to benefit from these favorable governmental policies and funding opportunities. ## Future Outlook The [High Flow Nasal Cannula Market](https://www.marketresearchfuture.com/reports/high-flow-nasal-cannula-market-22169) is projected to grow at a 12.99% CAGR from 2025 to 2035, driven by technological advancements and increasing patient demand. **New opportunities:** - Development of portable high flow-nasal-cannula devices for home care settings. - Partnerships with telehealth platforms for remote patient monitoring solutions. - Expansion into emerging markets with tailored product offerings. By 2035, the market is expected to achieve substantial growth, driven by innovation and strategic partnerships. ## Segment Insights ### By Component: Nasal Cannulas (Largest) vs. Air Humidifiers (Fastest-Growing) In the South Korea high flow-nasal-cannula market, the component segment is primarily dominated by nasal cannulas, which hold a significant market share, followed closely by air humidifiers. Other components like single heated tubes, air/oxygen blenders, and various other devices contribute to the overall landscape, but they represent a smaller share of the market. The distribution indicates a strong preference for nasal cannulas among healthcare providers, reflecting their critical role in respiratory therapies. Growth trends show a robust demand for air humidifiers, which are emerging as the fastest-growing component in this segment. This increase is driven by advancements in technology and the rising awareness of the benefits of humidification in enhancing patient comfort and oxygen delivery effectiveness. Additionally, the growing prevalence of respiratory diseases is pushing overall market growth, supporting the diverse needs in respiratory care. Nasal Cannulas (Dominant) vs. Air Humidifiers (Emerging) Nasal cannulas are the dominant component in the South Korea high flow-nasal-cannula market, widely recognized for their effectiveness, comfort, and ease of use in managing patients' respiratory requirements. They are favored in both hospital and home care settings, offering a reliable solution for delivering supplemental oxygen. On the other hand, air humidifiers are gaining traction as an emerging component, essential for maintaining optimal humidity levels during oxygen therapy. This helps prevent airway irritation and enhances patient compliance. As we observe the market dynamics, the evolution of both nasal cannulas and air humidifiers showcases a significant shift towards integrated respiratory management solutions, elevating patient care quality. ### By Application: Chronic Obstructive Pulmonary Disease (COPD) (Largest) vs. Sleep Apnea (Fastest-Growing) In the South Korea high flow-nasal-cannula market, Chronic Obstructive Pulmonary Disease (COPD) holds the largest market share among application segments. This dominance is driven by the increasing prevalence of COPD due to factors such as smoking and environmental pollutants. Other notable segments include Sleep Apnea, which is rapidly gaining traction due to rising awareness and diagnosis of this condition, indicating a diversified market catering to various respiratory needs. Growth trends indicate a strong upward trajectory for applications like Sleep Apnea, which is becoming increasingly recognized and treated. The rise in an aging population coupled with lifestyle changes amplifies the demand for high flow-nasal-cannulas across these segments. Furthermore, advancements in technology and therapies for respiratory support continue to bolster the market, ensuring that products meet contemporary healthcare requirements efficiently. COPD (Dominant) vs. Sleep Apnea (Emerging) COPD is currently the dominant application in the South Korea high flow-nasal-cannula market, largely due to its association with significant morbidity and mortality among adults. The increasing incidence of COPD is matched by a robust growth in research and development efforts focused on effective management strategies. In contrast, Sleep Apnea is emerging as a significant segment, driven by improved awareness and healthcare interventions. Patients are increasingly seeking diagnosis and treatment options due to a better understanding of the condition's implications for overall health. Both segments highlight the crucial role of high flow-nasal-cannulas in enhancing patient outcomes by providing precise and effective oxygen therapy tailored to individual needs. ### By End-user: Hospitals (Largest) vs. Long-Term Care Centers (Fastest-Growing) In the South Korea high flow-nasal-cannula market, Hospitals hold the predominant market share, attributed to the increasing number of admissions and advancements in respiratory care technology. Long-Term Care Centers are rapidly gaining traction, reflecting a shift towards outpatient solutions and home care as more patients prefer continuity in their respiratory treatment plans. Growth trends indicate a robust expansion for both Hospitals and Long-Term Care Centers due to an increasing prevalence of respiratory diseases and an aging population. The rise in demand for home healthcare solutions is propelling Long-Term Care Centers to the forefront, while Hospitals continue to innovate in therapeutic techniques. Enhanced patient care focuses drive the market forward, enhancing overall service quality. Hospitals (Dominant) vs. Long-Term Care Centers (Emerging) Hospitals play a dominant role in the South Korea high flow-nasal-cannula market, driven by extensive resources and capabilities to treat acute conditions. They are equipped with cutting-edge medical technologies and skilled healthcare professionals, ensuring comprehensive respiratory management for patients. Meanwhile, Long-Term Care Centers represent an emerging segment characterized by personalized patient care and an emphasis on long-term management of respiratory conditions. These centers are increasingly recognized for their ability to provide quality care in community settings, catering to the preferences of patients who wish to avoid hospital stays. This shift mirrors evolving healthcare trends towards more accessible and sustainable treatment options. ## Competitive Benchmarking The high flow-nasal-cannula market in South Korea is characterized by a competitive landscape that is increasingly shaped by innovation and strategic partnerships. Key players such as Fisher & Paykel Healthcare (NZ), Medtronic (IE), and Philips (NL) are actively pursuing growth through technological advancements and regional expansions. Fisher & Paykel Healthcare (NZ) focuses on enhancing patient comfort and outcomes through its innovative product designs, while Medtronic (IE) emphasizes its commitment to integrating advanced technologies into its respiratory solutions. Philips (NL) is leveraging its expertise in digital health to create connected solutions that improve patient management, thereby enhancing its competitive positioning in the market.The business tactics employed by these companies reflect a trend towards localizing manufacturing and optimizing supply chains to meet the specific needs of the South Korean market. The competitive structure appears moderately fragmented, with several players vying for market share. However, the collective influence of these key players is significant, as they drive innovation and set industry standards that smaller companies must follow. In October Fisher & Paykel Healthcare (NZ) announced the launch of a new high flow-nasal-cannula system designed to improve oxygen delivery efficiency. This strategic move is likely to enhance their market share by addressing the growing demand for effective respiratory solutions in critical care settings. The introduction of this product aligns with the company's focus on patient-centric innovations, potentially solidifying its leadership position in the market. In September Medtronic (IE) expanded its partnership with local healthcare providers to enhance the distribution of its high flow-nasal-cannula products. This collaboration is strategically important as it allows Medtronic to leverage local expertise and improve its market penetration, thereby increasing accessibility to its advanced respiratory solutions. Such partnerships may also facilitate better alignment with regulatory requirements and patient needs in South Korea. In August Philips (NL) unveiled a new digital platform that integrates its high flow-nasal-cannula products with telehealth capabilities. This initiative is indicative of the growing trend towards digitalization in healthcare, allowing for remote monitoring and management of patients. By embracing technology, Philips is not only enhancing patient care but also positioning itself as a leader in the integration of digital health solutions within the respiratory market. As of November the competitive trends in the high flow-nasal-cannula market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence. Strategic alliances among key players are shaping the landscape, fostering innovation and enhancing product offerings. The shift from price-based competition to a focus on technological advancements and supply chain reliability is evident, suggesting that future competitive differentiation will hinge on the ability to innovate and adapt to evolving market demands. ## Recent News & Developments Recent developments in the South Korea High Flow Nasal Cannula Market have been marked by increased demand due to the ongoing focus on respiratory care, particularly stemming from the COVID-19 pandemic. As healthcare facilities expand their capabilities, companies like Philips, ResMed, and Fisher and Paykel Healthcare have been actively enhancing product offerings to meet clinical needs. In terms of mergers and acquisitions, notable movements include ResMed acquiring an undisclosed respiratory device company in July 2023, aimed at broadening its product portfolio in South Korea. Furthermore, during 2022, Drive DeVilbiss Healthcare launched innovative cannula designs that cater to patients' comfort, thus strengthening their market presence. Market valuations for these firms continue to grow, with Air Liquide reporting a substantial increase in their revenue attributed to higher demand for medical gases and respiratory devices. The South Korean government is investing in advanced medical technologies, contributing to the overall growth of the market. Companies are also focusing on Research and Development to innovate and create high-quality products that cater to the evolving healthcare landscape in South Korea. ## Report Scope | MARKET SIZE 2024 | 178.0(USD Million) | | --- | --- | | MARKET SIZE 2025 | 201.12(USD Million) | | MARKET SIZE 2035 | 682.0(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 12.99% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Fisher & Paykel Healthcare (NZ), Medtronic (IE), Philips (NL), ResMed (AU), Smiths Medical (GB), Teleflex (US), Vyaire Medical (US), Becton Dickinson (US) | | Segments Covered | Component, Application, End-user | | Key Market Opportunities | Growing demand for advanced respiratory support solutions drives innovation in the high flow-nasal-cannula market. | | Key Market Dynamics | Rising demand for high flow-nasal-cannula driven by advancements in respiratory care technologies and regulatory support. | | Countries Covered | South Korea | ## Frequently Asked Questions **Q: What was the market valuation of the high flow-nasal-cannula market in 2024?** A: The market valuation was $178.0 Million in 2024. **Q: What is the projected market valuation for the high flow-nasal-cannula market by 2035?** A: The projected valuation for 2035 is $682.0 Million. **Q: What is the expected CAGR for the high flow-nasal-cannula market during the forecast period 2025 - 2035?** A: The expected CAGR during this period is 12.99%. **Q: Which companies are considered key players in the high flow-nasal-cannula market?** A: Key players include Fisher & Paykel Healthcare, Medtronic, Philips, ResMed, Smiths Medical, Teleflex, Vyaire Medical, and Becton Dickinson. **Q: What were the revenue figures for Nasal Cannulas in 2024?** A: Nasal Cannulas generated revenue between $60.0 Million and $230.0 Million in 2024. **Q: How much revenue is projected for Air Humidifiers by 2035?** A: Air Humidifiers are projected to generate revenue between $40.0 Million and $150.0 Million by 2035. **Q: What is the revenue range for Chronic Obstructive Pulmonary Disease (COPD) applications in 2024?** A: COPD applications had a revenue range of $60.0 Million to $240.0 Million in 2024. **Q: Which end-user segment is expected to dominate the market by 2035?** A: Hospitals are expected to dominate the market, with projected revenues between $100.0 Million and $400.0 Million by 2035. **Q: What was the revenue for Acute Respiratory Failure applications in 2024?** A: Acute Respiratory Failure applications generated revenue between $30.0 Million and $120.0 Million in 2024. **Q: What is the expected revenue range for Long-Term Care Centers by 2035?** A: Long-Term Care Centers are expected to generate revenue between $20.0 Million and $80.0 Million by 2035. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/south-korea-high-flow-nasal-cannula-market-52231*